SEC Form 4 · accession 0001185185-17-001113
IGC Pharma, Inc. · IGC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Ram Mukunda
Officer — Exec. Chairman & CEO · Director
Period of report
May 9, 2017
Accepted (ET)
May 11, 2017 · 7:55 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001326205
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common stockF1,F2 | May 9, 2017 | A | 150,000 | $0.00 | A | 792,289 | I | By Spouse |
| Common stockF1 | May 9, 2017 | A | 569,994 | $0.00 | A | 2,596,944 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents shares of Common Stock awarded pursuant to the Issuer's 2008 Omnibus Incentive Plan.
- F2Represents shares held directly by Mr. Mukunda's spouse.